Clinical trials
Chest Wall Tumor clinical trials
Below are recruiting chest wall tumor clinical trials, each written for real people, not researchers. We’re tracking 6 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07018960Recruiting
Chest wall repair with custom 3D-printed titanium implant
This study is testing a new way to repair large chest wall defects using a custom-made 3D-printed titanium implant. It may help people who need chest wall reconstruction after cancer surgery, a bad injury, or damage from infection or radiation.
Cruces, Basque CountryAges 18 years+ - NCT03971045RecruitingPhase 2
Pembrolizumab plus low-dose oral chemo for chest wall breast cancer
This Phase 2 trial tests pembrolizumab (an immune therapy) plus low-dose oral cyclophosphamide in people with chest wall breast cancer that has spread locally and may have distant metastases. It aims to see if this combination can shrink tumors and control cancer longer, especially in tumors with certain immune markers.
MilanAges 18 years+ - NCT07338006Recruiting
Chest wall reconstruction study
This trial studies patients who need surgery to rebuild part of their chest wall after a defect. It looks at how well different reconstruction methods work, especially for larger defects that can't be simply closed.
Lahore, Punjab ProvinceAges 18 years+ - NCT06464913RecruitingPhase 2
Chest wall radiation omission after breast implant reconstruction
This study tests whether skipping chest wall radiation after breast implant reconstruction is safe and effective for patients with stage T1-2N1 breast cancer. It may help avoid side effects from radiation while still controlling the cancer.
Hangzhou, ZhejiangAges 18–70 - NCT05896865Recruiting
Personalized breast cancer radiation based on tumor biology
This trial studies whether adjusting radiation dose using how the tumor behaves can improve outcomes for people with locally advanced breast cancer that has spread to certain nearby lymph nodes. It may help deliver the right radiation intensity while avoiding unnecessary exposure.
SeoulAges 19 years+ - NCT06331455RecruitingPhase 2
Radiation, immunotherapy, and surgery for chest wall lung cancer
This trial tests combining radiation, immunotherapy (durvalumab), and surgery for people with non-small cell lung cancer that has spread to the chest wall or top of the lung. It aims to see if this approach can help remove the cancer completely.
TorontoAges 18–99
Hear when a new Chest Wall Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for chest wall tumor?
- Yes. Clin2 currently lists 6 recruiting chest wall tumor studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a chest wall tumor trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a chest wall tumor trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.